Ho Young Lim

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

Sandrine Faivre, Éric Raymond, Éveline Boucher et al. · The Lancet Oncology · 2009 · 288 citations

Hepatology, Medicine, Pharmacology +8

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer

Chul Kim, Jae‐Lyun Lee, Min‐Hee Ryu et al. · Investigational New Drugs · 2009 · 82 citations

Gastrointestinal Oncology, Medicine, Cancer Management +6

Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum

Jae‐Lyun Lee, Jin‐Hee Ahn, Se Hoon Park et al. · Investigational New Drugs · 2011 · 71 citations

Urology, Polymer-drug Conjugate, Medicine +7

Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-κB inhibition and PPAR activation signal pathway

Nguyễn Xuân Nhiệm, Ho Young Lim, Phan Văn Kiệm et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 44 citations

Aralia Elata, Oleanane-type Triterpene Saponins, Biochemistry +5

Multi-Institutional Phase II Study of S-1 Monotherapy in Advanced Gastric Cancer with Pharmacokinetic and Pharmacogenomic Evaluations

Hei‐Cheul Jeung, Sun Young Rha, Hoon Kyo Kim et al. · The Oncologist · 2007 · 33 citations · Full text